Citigroup Inc Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Citigroup Inc

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $409,635 - $480,704	400 Added 0.99%	41,000 $43.1 Million
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $3.53 Million - $4.28 Million	4,000 Added 10.93%	40,600 $42.7 Million
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $722,152 - $794,680	800 Added 2.23%	36,600 $35.2 Million
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $67.8 Million - $77.1 Million	-87,400 Reduced 70.94%	35,800 $31.4 Million
Q3 2023 Nov 09, 2023	BUY	$692.45 - $844.37 $64.3 Million - $78.4 Million	92,800 Added 305.26%	123,200 $101 Million
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $8.4 Million - $9.96 Million	12,000 Added 65.22%	30,400 $21.8 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $10.1 Million - $12.3 Million	14,900 Added 425.71%	18,400 $15.1 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $7.06 Million - $7.66 Million	-10,000 Reduced 74.07%	3,500 $2.53 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $5.74 Million - $7.24 Million	10,000 Added 285.71%	13,500 $9.3 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $5.24 Million - $6.15 Million	-8,800 Reduced 71.54%	3,500 $2.44 Million
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $10.1 Million - $12.4 Million	-18,500 Reduced 60.06%	12,300 $7.77 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $17.7 Million - $21 Million	30,800 New	30,800 $18.6 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.